Robert Cavaliere MD
Robert Cavaliere MD
Starling Loving Hall 320 W 10th Avenue Columbus OH 43210
General Research InterestPrimary and metastatic brain cancer, quality of life outcomes, experimental therapeutics.
Research Description• The development of therapies for patients with metastatic and primary brain tumors that prolong and improve their lives.
• The evaluation of the processes and treatments currently employed for their true effectiveness and impact on quality of life.
• The study of certain high-risk populations (including the elderly and those significantly impaired by their disease) in which the small gains of treatment must be balanced against the increased risk of treatment toxicity and complications.
Transinstitutional WorkCollaboration of all members of the neuro-oncology treatment team, including medical neuro-oncology, neurosurgery and radiation oncology, is critical to the successful delivery of care. For this reason, a multidisciplinary neuro-oncology clinic was established at The James to accommodate patients with such complex diseases.
The development of novel therapies to treat brain cancers requires close collaboration with basic scientists, in whose labs drugs are first conceived and tested. Through this partnership, promising agents are identified and translated into clinical studies for patients.
Successful care requires team members to address the daily needs of patients: psychological, financial, physical and social needs. Our neuro-oncology nurses, social workers and counselors focus all their attention on these needs.
Hafeez S, Cavaliere RRecent innovations in the management of low-grade gliomas.Curr Treat Options Neurol 14(4) 369-80 8/1/2012
Goldlust SA, Cavaliere R, Newton HB, Hsu M, Deangelis LM, Batchelor TT, Gilbert MR, Lassman ABBevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors.J Neurooncol 107(2) 407-11 4/1/2012
Sheehan JM, Cavaliere R, Farace E, Bredel M, Burri SHGlioblastoma multiforme.Neurol Res Int 2012 819304 1/1/2012
Cohen JB, Cavaliere R, Byrd JC, Andritsos LAHearing Loss due to Infiltration of the Tympanic Membrane by Chronic Lymphocytic Leukemia.Case Rep Hematol 2012 589718 1/1/2012
© The Ohio State University